Delivery Order SPE2DB24D2100-SPE2DB25FBGET
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $24,729.86 firm fixed price delivery order for Tenkase 50 mg kits, with a completion date of August 29, 2025. This was a competitively awarded, non-set-aside contract with performance located at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $1,368.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically ALBUKED-25 VIAL 100ML, with performance in Conshohocken, Pennsylvania and an ultimate completion date of September 24, 2025. This non-set-aside competitive award was issued on September 3, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $20,460.00 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under a competitive process with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $12,821.24 to AmerisourceBergen Drug Corp on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,229.04 to AmerisourceBergen Drug Corp on September 7, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from the vendor's Corporate Office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,740.75 to AmerisourceBergen Drug Corp on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a $22,129.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,535.20 to AmerisourceBergen Drug Corp on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,230.00 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed in...
- The Defense Logistics Agency Medical Supply Chain awarded a $15,484.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 6, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order calls for pharmaceutical products...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGETDelivery Order
The Defense Logistics Agency awarded a $20.4K firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tenkase 25 mg vials. This non-set-aside competitive award is a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9M global pharmaceutical support vehicle active through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive federal contract portfolio. The company's DLA prime contract enables the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order supports the Defense Health Agency and other government healthcare systems, demonstrating AmerisourceBergen's capacity to fulfill federal medical supply requirements through open competition and firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 9/8/25 |